Search Results
Results found for "Tao Che"
- How to Design GPCR Drugs That Work in Vivo: Strategy, Tools, and Insights
Unlock On-Demand Yearly Access Now — Premium Members Get Over 50% Discount at Checkout ➤ Revvity x Dr scientists actually need—and validating it where it counts. 🎧 Go behind the scenes with Revvity —from the chemistry
- GPCR Drug Discovery at Discovery on Target: Why This Track Is About More Than Receptors
Here’s who we've talked to so far: 🎥 Check out the interview with Dr. from UNC and Terry's Corner We'll continue to update this section as new videos are released — so check
- Mechanism vs. Assumption: A Model-First Path to Getting GPCR MoA Right
Unlock real SAR: Deconvolute potency into affinity vs. efficacy to make medicinal chemistry cycles more
- From Snapshots to Predictions: Why Mechanism of Action Matters
Internal checks (like requiring a Schild regression slope of unity for competitive antagonism) add further Chemists suddenly have meaningful levers to pull. The lesson: models don’t just need data. shifted curves left Sometimes it raised baseline activity Sometimes it boosted the maximum response Chemists
- How to Use Statistical Methods to Strengthen Every GPCR Drug Discovery Decision
Must-read publications: A structural modeling study revealing non-canonical mechanisms of chemokine-driven
- Applications of Fluorescent Probes in Confocal Imaging of GPCRs: From Live to Fixed Cells
Come check out our products or contact us for more information!
- GPCR Happy Hour – Boston, Sept 2025
Axxam’s capabilities span the full spectrum of GPCR families, including aminergic, peptide, lipid, and chemosensory
- Fluorescence Polarization in GPCR Research
Adapted from: Zhang Y, Tang H, Chen W, Zhang J. ACS Med Chem Lett. 2022 Jan 10;13(2):243-249. doi: 10.1021/acsmedchemlett.1c00598.
- Advantages of Fluorescent Probes in GPCR Assays
ACS Chem Biol. 2014 Sep 19;9(9):1918-28. doi: 10.1021/cb5004042.
- Differential binding of Δ9-tetrahydrocannabinol derivatives to type 1 cannabinoid receptors (CB1)
If you want to check out the Materials and Methods section as well as the application note, here is the
- A robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery.
Chemical structure of [3H-CP-55940]. with even more diversity in chemical structures and affinities for other receptors. If you want to read the materials and methods section check out the link to the full article. Chem. Chem. 2006 , 49 (1), 70–79. https://doi.org/10.1021/jm050467q .
- Radioligands vs. Fluorescent Ligands: Binding Assays
They have several advantages, such as the minimal chemical modifications in the original ligand, high Tritium (3H) labeled ligands are usually chemically identical to the original, because tritium will usually specific activity, but a shorter half-life (60 days), which complicates storage, besides changing the chemical
- Fluorescence based HTS compatible ligand binding assays for dopamine D3 receptors in baculovirus preparations and live cells
determined to be 30.1 ± 1.7 nM corresponding to apparent Ki ± SEM = 15.7 ± 0.9 nM according to the Cheng-Prusoff Journal of Biological Chemistry 2005 , 280 (3), 2176–2185. https://doi.org/10.1074/jbc.M410385200 Chem. 2022 , 65 (6), 4832–4853. https://doi.org/10.1021/acs.jmedchem.1c02033 . (18) Dempsey, C.; Chen, K. H.; Bates, M.; Zhuang, X.
- Conjugation Strategies for Probe Development
This is Lucía from the Celtarys Research chemistry team. You can check what we do here on our website! In Comprehensive Analytical Chemistry ; Verma, S. K., Das, A. Bioconjugate Chem. 2015 , 26 (1), 145–152. https://doi.org/10.1021/bc5005262 . Chem. Rev. 2008 , 108 (8), 2952–3015. https://doi.org/10.1021/cr0783479 .
- The Imprecision Problem: Why Your GPCR Drug Discovery Program Is Off-Track Before It Even Starts
Bring in a computational chemist. Add a data scientist. Surely more hands will move the needle.
- Decoding Olfactory GPCRs: How AlphaFold and AI Are Changing the Game
That’s where computational chemistry steps in. This case study highlights why computational chemistry is no longer a side tool—it’s a driver of discovery
- GPCR Allosteric Modulation: Why Allostery is the Engine of Drug Discovery
You’ll see how this manifests in real data from muscarinic receptors, CCR5 chemokine programs, and NMDA
- Your GPCR Program Decisions Depend on Good Data Interpretation
GPCR University Learner Celtarys Research Recap: Medicinal Chemistry Highlights You May Have Missed The pace of innovation in medicinal chemistry is accelerating—and if you missed this year’s ACSMEDI-EFMC Medicinal Chemistry Frontiers 2025 , you’re already behind.
- GPCR Allostery: Unlock Hidden Mechanisms and Make Smarter Drug Decisions
. 🔍 This Week in Premium: Sneak Peek Industry insights: Strategic biotech alliances (Chemspace/Enamine
- How Understanding Intracellular Drug Access Can Transform Your GPCR Drug Discovery Program
He shares his journey into computational chemistry and offers a compelling look at how tools like AlphaFold
- Understanding Orthosteric Binding: The Key to Drug Action
It’s about a dynamic dance of chemical forces, equilibrium shifts, and molecular decisions that determine The dynamic interplay of chemical forces shapes drug effectiveness.
- Why Sokhom Pin Never Left GPCRs, Even When Everyone Else Did
Pin stayed loyal to GPCRs , even when big pharma turned its gaze to other targets like kinases and checkpoint
- Pharmacology at Your Fingertips: Terry’s Corner Launches
Plus: must-read chemokine and PTH1R papers, and new momentum across biotech—from Superluminal to Neurocrine Read The Full Article GPCR Publication Highlights Chemokine–GPCR Selectivity Unveiled Sequence- and structure-based analysis reveals how conserved and variable regions across chemokines and their receptors
- Unlock the Hidden Complexity Behind GPCRs—From Terry Kenakin’s Vault
Here’s the surprising truth: up to 80% of GPCR-targeted drugs fail—not because of poor chemistry, but
- Signals in Motion: Pain, Metabolism & Terry’s Corner
Blocking this chemokine axis reduces pain hypersensitivity by dampening neuroinflammation and glial
- Pharmacology Isn't What You Think—It's So Much More
You’ll uncover: Why pharmacology is the glue between chemistry and biology How to interpret drug behavior
- Beyond the Probe: Scaling Innovation From the Bench to Product Launch
Maria Majellaro Celtarys specializes in the custom development of fluorescent ligands using a modular chemistry But what sets them apart isn’t just chemistry. It’s empathy. Democratize access to high-performance chemical probes and make assay development faster, cheaper, and
- Terry’s Corner, Celtarys' Leap, and the $7B GPCR Horizon
GPCR Partner Tools The Story Behind Celtarys – From Chemistry to Company How does a medicinal chemist
- Dr. GPCR and Celtarys Research Join Forces to Expand Access to Innovative GPCR Tools
Celtarys Research develops high-quality, fluorescently labeled ligands and innovative chemical biology “This partnership will help accelerate the adoption of our chemical tools and foster collaborations that Celtarys Research is a biotech company based in Spain that specializes in the development of optimal chemical Their proprietary chemistry platform enables rapid generation of conjugates, such as labeled ligands,
- Inside Out: Mapping GPCRs from Membrane Codes to Market Moves
Check out our new on-demand course on non-canonical GPCR behaviors and a podcast episode tracing 30 years






























